2023
Unlocking the Proteome - The NULISA™ Platform
Entrant
Halteres Associates
Category
Video, Commercial & Film - Animation
Client's Name
Alamar Biosciences
Country / Region
United States
Unlocking the Proteome -The NULISA™ Platform sets a new standard in proteomic analysis with attomolar sensitivity, allowing for unprecedented biomarker detection and quantitation.
By leveraging a proprietary sequential immunocomplex capture and release mechanism and the latest advances in Next Generation Sequencing (NGS), the NULISA technology provides both ultra-high sensitivity and scalable multiplexing.
Credits
Entrant
The Next Practice
Category
Website - Science / Technology
Country / Region
United States
Entrant
AML Communications Limited
Category
Advertising - Billboard
Country / Region
United Kingdom
Entrant
American Kidney Fund
Category
Video, Commercial & Film - Educational
Country / Region
United States
Entrant
Chugai Pharmaceuticals
Category
Strategic Program - Research / Study
Country / Region
United States